Publisher
Springer Science and Business Media LLC
Subject
Critical Care and Intensive Care Medicine,Clinical Neurology
Reference81 articles.
1. Moura C, Acurcio F, Belo N. Drug–drug interactions associated with length of stay and cost of hospitalization. J Pharm Pharm Sci. 2009;12(3):266–72.
2. Papadopoulos J. Common drug interactions leading to adverse drug events in the intensive care unit: management and pharmacokinetic considerations. In: Papadopoulos J, Cooper B, Kane-Gill S, Corbett SM, Jeffrey B, editors. Drug-induced complications in the critically ill patient: a guide for recognition and treatment. 1st ed. Mt Prospect: Society of Critical Care Medicine; 2012. p. 401–12.
3. Uijtendaal EV, Van Harssel LLM, Hugenholtz GWK, et al. Analysis of potential drug–drug interactions in medical intensive care unit patients. Pharmacotherapy. 2014;34(3):213–9.
4. Smithburger PL, Kane-Gill SL, Seybert AL. Drug–drug interactions in the medical intensive care unit: an assessment of frequency, severity and the medications involved. Int J Pharm Pract. 2012;20(6):402–8.
5. Smithburger PL, Kane-Gill SL, Seybert AL. Drug–drug interactions in cardiac and cardiothoracic intensive care units: An analysis of patients in an academic medical centre in the US. Drug Saf. 2010;33(10):879–888.
Cited by
6 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献